HOME >> BIOLOGY >> NEWS
Award lectures for ASBMB's 2007 Annual Meeting

BETHESDA The 2007 annual meeting of the American Society for Biochemistry and Molecular Biology (ASBMB) will feature the latest news about cell biology, signaling pathways, and genome dynamics, with 156 presentations in over 50 sessions. The meeting will also include award lectures and sessions on educational and professional development, minority affairs studies, and the interplay between the biomedical sciences and public policy. The meeting will take place at the Washington Convention Center, 801 Mt. Vernon Place, NW, Washington, D.C., from April 28 to May 2.

The ASBMB meeting is part of a multi-society meeting called Experimental Biology 2007 (EB 2007), which also includes the annual meetings of the American Association of Anatomists, the American Physiological Society, the American Society for Investigative Pathology, the American Society for Nutrition, and the American Society for Pharmacology and Experimental Therapeutics.

Members of the media need to register during the meeting at the EB 2007 Press Room, located in the Convention Center East Registration Level 1.

Brief descriptions of the Award Lectures follow. The times indicated below may vary depending on the time taken by preceding presentations.

SATURDAY, APRIL 28

ASBMB Opening Lecture and Herbert Tabor/Journal of Biological Chemistry Lectureship 6:05 p.m.-6:50 p.m., Ballroom C
"Tyrosine Phosphorylation: From Discovery to the Kinome and Beyond"
TONY HUNTER, American Cancer Society Professor of Molecular and Cell Biology at the Salk Institute for Biological Studies, La Jolla, Calif., will discuss the latest results on studies of the human kinome a catalogue of genes that express key cellular proteins called protein kinases. Mutations in these genes have been found to cause various diseases, including cancer, which explains the current high interest in this topic.

ASBMB Opening Lecture and Herbert Tabor/Journal of Biol
'"/>

Contact: Pat Pages
ppages@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
23-Apr-2007


Page: 1 2 3 4

Related biology news :

1. Awards celebrating women and biotech brilliance
2. Serica scientists win AOSSM Award for ACL (knee) tissue regeneration in preclinical study
3. ASM scores a hat-trick at the 2007 Hermes Creative Awards
4. Developer of new method for treating bone defects wins WPI Entrepreneurship Award
5. Ossurs PROPRIO FOOT takes the Gold 2007 Medical Design Excellence Award
6. Michael R. Zalutsky receives SNMs 2007 Paul C. Aebersold Award
7. SNM recognizes R. Edward Coleman with 2007 Georg Charles de Hevesy Nuclear Pioneer Award
8. Scientists honored with Excellence in Clinical Research Award
9. 2007 Alzheimer Award to Jing Zhang, M.D., Ph.D.
10. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
11. JDRF announces 2007 Scholar Award recipients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Award lectures for ASBMB Annual Meeting

(Date:6/18/2013)... Arlington environmental engineer has been awarded a $394,300 ... ensure water quality and flow in the new ... Andrew Kruzic, UT Arlington associate professor of civil ... to add monochloramine to the water in an ... pump stations and pipelines. Adding monochloramine is widely ...
(Date:6/18/2013)... The National Institutes of Health has awarded $12.7 ... a selection of pharmaceutical industry compounds to explore ... including Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. ... Uses for Existing Molecules, is led by the ... funded by the NIH Common Fund. , The ...
(Date:6/18/2013)... 10% of breast and ovarian cancers are familial in ... attributable to inherited mutations from the parents in genes ... mutations, PARP inhibitors, which are currently in clinical trials, ... option for personalised cancer treatment, an alternative to standard ... of these patients generate resistance to the drug and, ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 India’s ... business can potentially be worth up to a ... opportunity, the Indian government is taking serious action ... the process. , This presentation will examine:, ... regulations ,     Immediate and long term impacts ...
(Date:6/19/2013)... Applied Rigaku Technologies, Inc. is pleased to publish ... sulfur in ultra-low sulfur diesel (ULSD) using the new ... . The analysis detailed in Rigaku Application Note 1272 ... International Standard specifies an energy dispersive X-ray fluorescence (EDXRF) ... automotive gasoline. , Regulations around the world have limited ...
(Date:6/19/2013)... A new look at “big glass” and visionary ... highlight technical sessions at SPIE Photomask Technology 2013 ... year, the three-day event is the industry’s largest mask ... 100 technical presentations and numerous networking lunches and receptions. ... and photonics , the meeting will be held at ...
(Date:6/19/2013)... Express Diagnostics Int’l, Inc., manufacturer of ... it has received Class III medical device license approval ... DrugCheck® NxStep Onsite Drug Screen Cup in Canada. ... device in near-patient settings, such as physicians’ offices. , ... Canada Class III approval for 24 different drugs and ...
Breaking Biology Technology:Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
Cached News: